Answer
Serious infections reported with infliximab include tuberculosis, bacterial infections including sepsis and pneumonia, invasive fungal, viral and other opportunistic infections, including pneumocystosis, candidiasis, listeriosis and aspergillosis; some infections have been fatal.
Sources for this answer
- Remicade 100mg powder for concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 75Document updated
Sources checked